Literature DB >> 11369535

The roles of cholesterol in pulmonary surfactant: insights from comparative and evolutionary studies.

S Orgeig1, C B Daniels.   

Abstract

In most eutherian mammals, cholesterol (Chol) comprises approximately 8-10 wt.% or 14-20 mol.% of both alveolar and lamellar body surfactant. It is regarded as an integral component of pulmonary surfactant, yet few studies have concentrated on its function or control. Throughout the evolution of the vertebrates, the contribution of cholesterol relative to surfactant phospholipids decreases, while that of the disaturated phospholipids (DSP) increases. Chol generally appears to dominate in animals with primitive bag-like lungs that lack septation, in the saccular lung of snakes or swimbladders which are not used predominantly for respiration, and also in immature lungs. It is possible that in these systems, cholesterol represents a protosurfactant. Cholesterol is controlled separately from the phospholipid (PL) component in surfactant. For example, in heterothermic mammals such as the fat-tailed dunnart, Sminthopsis crassicaudata, and the microchiropteran bat, Chalinolobus gouldii, and also in the lizard, Ctenophorus nuchalis, the relative amount of Chol increases in cold animals. During the late stages of embryonic development in chickens and lizards, the Chol to PL and Chol to DSP ratios decrease dramatically. While in isolated lizard lungs, adrenaline and acetylcholine stimulate the secretion of surfactant PL, Chol secretion remains unaffected. This is also supported in isolated cell studies of lizards and dunnarts. The rapid changes in the Chol to PL ratio in response to various physiological stimuli suggest that these two components have different turnover rates and may be packaged and processed differently. Infusion of [3H]cholesterol into the rat tail vein resulted in a large increase in Chol specific activity within 30 min in the lamellar body (LB) fraction, but over a 48-h period, failed to appear in the alveolar surfactant fraction. Analysis of the limiting membrane of the lamellar bodies revealed a high (76%) concentration of LB cholesterol. The majority of lamellar body Chol is, therefore, not released into the alveolar compartment, as the limiting membrane fuses with the cell membrane upon exocytosis. It appears unlikely, therefore, that lamellar bodies are the major source of alveolar Chol. It is possible that the majority of alveolar Chol is synthesised endogenously within the lung and stored independently from surfactant phospholipids. The role of cholesterol in the limiting membrane of the lamellar body may be to enable fast and easy processing by maintaining the membrane in a relatively fluid state.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369535     DOI: 10.1016/s1095-6433(01)00307-5

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Mol Integr Physiol        ISSN: 1095-6433            Impact factor:   2.320


  21 in total

1.  More than a monolayer: relating lung surfactant structure and mechanics to composition.

Authors:  Coralie Alonso; Tim Alig; Joonsung Yoon; Frank Bringezu; Heidi Warriner; Joseph A Zasadzinski
Journal:  Biophys J       Date:  2004-09-28       Impact factor: 4.033

2.  Palmitoylation of pulmonary surfactant protein SP-C is critical for its functional cooperation with SP-B to sustain compression/expansion dynamics in cholesterol-containing surfactant films.

Authors:  Florian Baumgart; Olga L Ospina; Ismael Mingarro; Ignacio Rodríguez-Crespo; Jesús Pérez-Gil
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

3.  Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids.

Authors:  Elena Lopez-Rodriguez; Mercedes Echaide; Antonio Cruz; H William Taeusch; Jesus Perez-Gil
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

4.  Prolonged survival of scavenger receptor class A-deficient mice from pulmonary Mycobacterium tuberculosis infection.

Authors:  Zvjezdana Sever-Chroneos; Amy Tvinnereim; Robert L Hunter; Zissis C Chroneos
Journal:  Tuberculosis (Edinb)       Date:  2011-11-15       Impact factor: 3.131

5.  Effect of Lung Surfactant Protein SP-C and SP-C-Promoted Membrane Fragmentation on Cholesterol Dynamics.

Authors:  Nuria Roldan; Thomas K M Nyholm; J Peter Slotte; Jesús Pérez-Gil; Begoña García-Álvarez
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

6.  A central theory of biology.

Authors:  John S Torday
Journal:  Med Hypotheses       Date:  2015-04-04       Impact factor: 1.538

7.  Environmental tobacco smoke effects on lung surfactant film organization.

Authors:  Patrick C Stenger; Coralie Alonso; Joseph A Zasadzinski; Alan J Waring; Chun-Ling Jung; Kent E Pinkerton
Journal:  Biochim Biophys Acta       Date:  2008-12-11

8.  Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant.

Authors:  Eleonora Keating; Luna Rahman; James Francis; Anne Petersen; Fred Possmayer; Ruud Veldhuizen; Nils O Petersen
Journal:  Biophys J       Date:  2007-05-25       Impact factor: 4.033

9.  Segregated phases in pulmonary surfactant membranes do not show coexistence of lipid populations with differentiated dynamic properties.

Authors:  Jorge Bernardino de la Serna; Greger Orädd; Luis A Bagatolli; Adam C Simonsen; Derek Marsh; Göran Lindblom; Jesus Perez-Gil
Journal:  Biophys J       Date:  2009-09-02       Impact factor: 4.033

10.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.